Stand der InformationAugust 2024
1 Module 2, 2.5: Povidone-iodine, Clinical Overview Addendum for Safety Label Variation, 02 Nov 2021.
2 Module 2, 2.5: Mundipharma Research Ltd. Povidone-iodine and skin discolouration. September 28, 2021.
3 Module 2, 2.5: Povidone-iodine, Clinical Overview Addendum for Safety Label Variation, 02 Nov 2021.
4 Module 2, 2.5: Mundipharma Research Ltd. Povidone-iodine and skin discolouration. September 28, 2021.
|